HuagongsheHuagongshe Chemistry Print Report · For research reference only
(S)-2-isobutyl-1-(2,2,2-trifluoroethyl)piperazine → 3-Amino-5-(6-((S)-3-isobutyl-4-(2,2,2-trifluoroethyl)piperazin-1-yl)-2-((S)-1-methoxypropan-2-ylamino)pyrimidin-4-yloxy)quinoxalin-2(1H)-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (S)-2-isobutyl-1-(2,2,2-trifluoroethyl)piperazine | HCID 58612005 | — |
| Reactant | (S)-3-amino-5-(6-chloro-2-(1-methoxypropan-2-ylamino)pyrimidin-4-yloxy)quinoxalin-2(1H)-one | HCID 58612053 | — |
| Product | 3-Amino-5-(6-((S)-3-isobutyl-4-(2,2,2-trifluoroethyl)piperazin-1-yl)-2-((S)-1-methoxypropan-2-ylamino)pyrimidin-4-yloxy)quinoxalin-2(1H)-one | HCID 11635469 | — |
Reaction Steps
The reaction of (S)-3-amino-5-(6-chloro-2-(1-methoxypropan-2-ylamino)pyrimidin-4-yloxy)quinoxalin-2(1H)-one (74 mg, 0.2 mmol, Example 122(b)) with (S)-2-isobutyl-1-(2,2,2-trifluoroethyl)piperazine (89 mg, 0.4 mmol) under the conditions of Example 34 provided the title compound as an amorphous solid. MS (ESI, pos. ion) m/z: 565 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07335672B2 |
| Source dataset | uspto-grants-2008_02 |
| ORD ID | ord-3dc15a5fa0ac417f9abb1778dac6ffff |
| Source note | uspto-grants-2008_02 |